As of December 2024 Hikma Pharmaceuticals has a market cap of S$7.39 Billion. This makes Hikma Pharmaceuticals the world's 2562th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.